MedTrace Logo

Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19

NCT04912895 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2023-09-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to learn how to better detect infection and understand how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes lung disease and is spread. The novel device called PneumoniaCheck is a safe way to collect material from the lung from coughs. Study participants will collect cough specimens over a 24 hour period.

Conditions

  • Covid19

Interventions

DEVICE

PneumoniaCheck

Participants are asked to do 5 sets of 10 coughs, with at least 15 minutes between sets, into the PneumoniaCheck device.

Sponsors & Collaborators

  • Georgia Tech Foundation

    collaborator OTHER

  • Emory University

    lead OTHER

Principal Investigators

  • Larry Anderson, MD · Emory University

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-14
Primary Completion
2022-08-05
Completion
2022-08-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04912895 on ClinicalTrials.gov